Sign In

Rachel King

Biotechnology Executive

Rachel King is a prominent figure in the biotechnology sector, currently serving as a member of the Board of Directors at Novavax, Inc. since 2018. She is also the co-founder and former CEO of GlycoMimetics, Inc., a biotechnology company focused on developing therapies for cancer and inflammatory diseases. King's extensive career spans over three decades, during which she has held various significant roles in both executive leadership and venture capital.

Professional Background

  • Novavax, Inc.: Rachel joined the board in November 2018, bringing her vast experience in biotechnology and pharmaceuticals to the company, which specializes in vaccine development for serious infectious diseases.17
  • GlycoMimetics, Inc.: She co-founded this clinical-stage biotechnology company in 2003 and served as its CEO until August 2021.23
  • Biotechnology Innovation Organization (BIO): King has been an influential leader within BIO, serving as CEO since November 2022 and previously holding various positions including Chair of the Board.56

Previous Experience

  • New Enterprise Associates (NEA): Before founding GlycoMimetics, she was an Executive in Residence at NEA, a leading venture capital firm.17
  • Novartis Corporation: Rachel held the position of Senior Vice President at Novartis from 1999 to 2001, contributing to significant advancements in pharmaceutical development.23
  • Genetic Therapy, Inc.: She spent ten years with this company, which included leading it through its initial public offering and eventual acquisition by Novartis, where she continued to serve as CEO of the subsidiary.48

Education

Rachel King earned her Bachelor of Arts degree from Dartmouth College and her MBA from Harvard Business School, equipping her with a strong foundation for her entrepreneurial and executive endeavors in biotechnology.24

Current Roles

In addition to her role at Novavax, Rachel serves on several boards including:

  • University of Maryland BioPark
  • MdBio, Inc.
  • Learning Undefeated, Inc.

Her leadership and expertise are recognized across the industry, making her a key player in advancing biotechnological innovations and addressing critical health challenges globally.37

Highlights

Jan 1 · bio.org
Rachel King - BIO International Convention
Apr 26 · genengnews.com
BIO CEO Rachel King Outlines Industry's Challenges on "Close to ...
Oct 11 · mmm-online.com
BIO taps Rachel King as interim president and CEO

Related Questions

What are Rachel King's main responsibilities at Novavax?
How has Rachel King's career evolved over the years?
What are some of Rachel King's notable achievements in the biotechnology industry?
How does Rachel King's experience at Novartis influence her role at Novavax?
What are the key projects Rachel King has been involved in at GlycoMimetics?
Rachel King
Add to my network

Location

Gaithersburg, Maryland, United States